{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:51:30Z","timestamp":1759009890507},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.diagmicrobio.2006.08.018","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T12:02:17Z","timestamp":1173355337000},"page":"283-287","source":"Crossref","is-referenced-by-count":7,"title":["Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin"],"prefix":"10.1016","volume":"57","author":[{"given":"Claudio","family":"Piersimoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Lacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Penati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Iona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfranco","family":"Fattorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Nista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Zallocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Pietro","family":"Gesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Codecasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/AAC.42.8.2066","article-title":"In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis","volume":"42","author":"Baohong","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/427292","article-title":"Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Europe","volume":"40","author":"Bozeman","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"Burman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.rmed.2006.01.002","article-title":"Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs","volume":"100","author":"Codecasa","year":"2006","journal-title":"Respir. Med."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/mdr.1999.5.265","article-title":"Activity of 16 antimicrobial agents against drug-resistant of Mycobacterium tuberculosis","volume":"5","author":"Fattorini","year":"1999","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib6","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/AAC.49.7.2928-2933.2005","article-title":"Evaluation of new line probe assay for rapid identification of gyr A mutations in Mycobacterium tuberculosis","volume":"49","author":"Giannoni","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/44.3.393","article-title":"Activity of moxifloxacin against mycobacteria","volume":"44","author":"Gillespie","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/379328","article-title":"Fluoroquinolone resistance in patients with newly diagnosed tuberculosis","volume":"37","author":"Ginsburg","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib10","series-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","first-page":"89","article-title":"Drug susceptibility tests in the management of chemotherapy of tuberculosis","author":"Heifets","year":"1991"},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.47.2.653-657.2003","article-title":"Sterilizing activity of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis","volume":"47","author":"Hu","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first and second-line antimicrobial drugs with drug resistant clinical strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib13","series-title":"Susceptibility Testing of Mycobacteria, Nocardia and Other Aerobic Actinomycetes. Approved Standard M24-A","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1164\/rccm.2309011","article-title":"Development of fluoroquinolones as first-line drugs for tuberculosis\u2014at long last!","volume":"168","author":"O'Brien","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib15","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.48.3.780-782.2004","article-title":"Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective randomized study","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib17","first-page":"39","article-title":"Clinical use of levofloxacin in the long-term treatment of drug resistant tuberculosis","volume":"57","author":"Richeldi","year":"2002","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0924-8579(02)00239-X","article-title":"In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis","volume":"20","author":"Rodriguez","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib19","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/JCM.42.11.5225-5228.2004","article-title":"Validation of the use of 7H10 agar, BACTEC MGIT 960 and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin","volume":"42","author":"Sanders","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib20","series-title":"Clinical microbiology procedures handbook","first-page":"7.8.1.1","article-title":"BACTEC 460 TB (Radiometric) System. Indirect susceptibility testing for Mycobacterium tuberculosis","author":"Siddiqi","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib21","series-title":"Clinical microbiology procedures handbook","first-page":"7.8.5.1","article-title":"BACTEC MGIT 960 SIRE. Nonradiometric susceptibility testing for Mycobacterium tuberculosis","author":"Siddiqi","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib22","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.43.11.2793","article-title":"Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolones","volume":"43","author":"Sullivan","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib23","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/AAC.47.10.3117-3122.2003","article-title":"Fluoroquinolone-containing third line regimen against Mycobacterium tuberculosis in vivo","volume":"47","author":"Veziris","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib24","first-page":"1215","article-title":"Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia","volume":"9","author":"Yoon","year":"2005","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.diagmicrobio.2006.08.018_bib25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/174.5.1127","article-title":"Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis","volume":"174","author":"Xu","year":"1996","journal-title":"J. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T11:53:33Z","timestamp":1587383613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0732889306003348"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.08.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}